Citadel Advisors’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-37,895
| Closed | -$49.6K | – | 6209 |
|
|
2024
Q2 | $49.6K | Buy |
+37,895
| New | +$49.6K | ﹤0.01% | 5182 |
|
|
2022
Q4 | – | Sell |
-4,019
| Closed | -$22K | – | 6364 |
|
|
2022
Q3 | $22K | Buy |
+4,019
| New | +$22K | ﹤0.01% | 5514 |
|
|
2021
Q2 | – | Sell |
-2,976
| Closed | -$107K | – | 6709 |
|
|
2021
Q1 | $107K | Buy |
+2,976
| New | +$107K | ﹤0.01% | 5824 |
|